This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hypochondroplasia (disorder)
Information about Hypochondroplasia (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hypochondroplasia (disorder)
Most recent studies have shown that Hypochondroplasia (disorder) shares some biological mechanisms with acanthosis-nigricans, achondroplasia, bone-diseases-developmental, congenital-abnormality, craniosynostosis, developmental-delay-(disorder), dwarfism, dysplasia, growth-disorders, macrocephaly, osteochondrodysplasias, pseudoachondroplastic-spondyloepiphyseal-dysplasia-syndrome, shwachman-syndrome, skeletal-dysplasia, thanatophoric-dysplasia, turner-syndrome.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hypochondroplasia (disorder), and have been seen in publications frequently: Bone Development, Cartilage Development, Cell Adhesion, Cell Cycle, Cell Division, Cell Growth, Cell Maturation, Cell Motility, Chondrocyte Differentiation, Chondrocyte Proliferation, Cytokinesis, Endochondral Ossification, Glycosylation, Muscle Attachment, Nervous System Development, Ossification, Pathogenesis, Protein Secretion, Secretion, System Development
Quite a number of genes have been found to play important roles in Hypochondroplasia (disorder), such as CDKN1A, COL2A1, FGF2, FGF3, FGFR1, FGFR2, FGFR3, GGH, GH1, IGF1, MTSS1, RANGAP1, SHOX, SLC17A5, STAT1, TKT. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.